Sevka M J, Matthews S J, Nightingale C H, Izard M W, Fieldman A, Chow M S
Clin Pharmacol Ther. 1981 Mar;29(3):322-6. doi: 10.1038/clpt.1981.43.
Disopyramide hemodialysis and kinetics after 200 mg orally in six patients receiving long-term hemodialysis were examined. Mean volume of distribution (area) was 66.5 +/- 13 l. Mean times of the peak serum concentration and mean peak serum concentration were 2.3 +/- 0.9 hr and 3.1 +/- 0.9 microgram/ml. Mean absorption half-life (t 1/2) was 21.6 +/- 12.5 min. Mean disopyramide elimination t 1/2 during dialysis was 16.8 +/- 11.9 hr, not significantly different from mean elimination t 1/2 without dialysis of 16.1 +/- 5.2 hr. End-dialysis bath concentrations of disopyramide showed that not more than 2.4% of the dose was dialyzed during a 2-hr dialysis period. Our data indicate that at therapeutic concentrations disopyramide was not appreciably dialyzed.
对6例接受长期血液透析的患者口服200毫克后丙吡胺的血液透析及动力学情况进行了研究。平均分布容积(面积)为66.5±13升。血清浓度达峰时间均值和血清峰浓度均值分别为2.3±0.9小时和3.1±0.9微克/毫升。平均吸收半衰期(t 1/2)为21.6±12.5分钟。透析期间丙吡胺的平均消除半衰期为16.8±11.9小时,与未透析时的平均消除半衰期16.1±5.2小时无显著差异。丙吡胺透析结束时的透析液浓度表明,在2小时的透析期间,透析出的剂量不超过2.4%。我们的数据表明,在治疗浓度下,丙吡胺的透析效果不明显。